GLP2: 10mg | 20mg | 30mg

Science and Mechanism of Action
GLP-2T is a novel peptide that acts as a dual agonist, targeting both the GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide) receptors. Both GLP-1 and GIP are hormones that play significant roles in regulating blood sugar levels, appetite, and fat metabolism. GLP-1 helps increase insulin secretion, decrease glucagon secretion, and slow gastric emptying, leading to reduced appetite and improved blood sugar control. GIP, on the other hand, influences insulin secretion in response to food intake and also helps with fat metabolism. By stimulating both of these receptors, Tirzepatide enhances insulin sensitivity, promotes weight loss, and improves overall metabolic function, offering a comprehensive approach to managing conditions like obesity and type 2 diabetes.

Potential Side Effects
Tirzepatide can cause some side effects, most notably gastrointestinal issues. Common side effects include nausea, vomiting, diarrhea, and abdominal pain, which are often related to its action on gastric emptying and appetite regulation. While these symptoms tend to be mild and improve over time, they can be bothersome for some users. Rare side effects may include allergic reactions or more serious issues related to blood sugar control, so it’s essential to monitor any changes, especially for individuals with pre-existing health conditions.

Benefits to the Human Body
Tirzepatide offers significant benefits, primarily for individuals struggling with obesity or type 2 diabetes. The peptide has been shown to lead to considerable weight loss by reducing hunger and increasing feelings of fullness, making it easier for individuals to maintain a calorie deficit. Additionally, it improves blood sugar control and insulin sensitivity, helping to manage and potentially reverse type 2 diabetes. Beyond weight loss and glucose regulation, Tirzepatide may also reduce the risk of cardiovascular diseases by improving key metabolic markers. With its dual action on both GLP-1 and GIP receptors, Tirzepatide represents a promising treatment option for metabolic conditions, offering a more effective solution for long-term weight management and overall metabolic health.